{"id":"W4408856819","doi":"10.1016/j.omton.2025.200977","title":"Safety, efficacy and total cost of point-of-care manufactured anti-CD19 CAR-T cell therapy in India: VELCART trial","year":2025,"lang":"en","type":"article","venue":"Molecular Therapy Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Miltenyi Biotec; Indian Council of Medical Research","keywords":"CAR T-cell therapy; CD19; Cell therapy; Medicine; Internal medicine; Cell; Chimeric antigen receptor; Immunotherapy; Chemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009957578,0.0008653224,0.0009449179,0.0004300616,0.0003159392,0.001119615,0.000844863,0.001091779,0.004623745],"category_scores_gemma":[0.0006739037,0.0004110078,0.0009657945,0.0005288384,0.0008982286,0.0006385713,0.0003713194,0.002241183,0.0009704563],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009355882,"about_ca_system_score_gemma":0.001119214,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007562289,"about_ca_topic_score_gemma":0.001071268,"domain_scores_codex":[0.9996253,0.0001847775,0.00001223236,0.00003705522,0.00003543078,0.00010518],"domain_scores_gemma":[0.999568,0.00009391476,0.00009122989,0.00005640265,0.00001962805,0.0001707273],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.812502,0.04335947,0.01230779,0.0005264317,0.0008455046,0.0004796631,0.0002024761,0.003546213,0.01421991,0.0006471041,0.003146523,0.108217],"study_design_scores_gemma":[0.4985039,0.4604427,0.02727131,0.00005847931,0.0007451421,0.0005733644,0.0001191283,0.002144333,0.005040079,0.0005184685,0.004527613,0.00005553236],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9948564,0.0006845744,0.0003782527,0.0002486385,0.00004554922,0.0009857778,0.0007635597,0.00007307638,0.001964174],"genre_scores_gemma":[0.9940446,0.0004516873,0.0006256975,0.0003498646,0.00007650586,0.001053641,0.001350784,0.00001895138,0.002028223],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004623745,"threshold_uncertainty_score":0.01546794,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01531814843787584,"score_gpt":0.3357818229476246,"score_spread":0.3204636745097488,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}